NCT07585045 Effectiveness of Oral Magnesium Supplementation in Fibromyalgia Patients Not Responding to Standard Treatment
| NCT ID | NCT07585045 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Shaikh Zayed Hospital, Lahore |
| Condition | Fibromyalgia |
| Study Type | INTERVENTIONAL |
| Enrollment | 86 participants |
| Start Date | 2026-04-16 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 86 participants in total. It began in 2026-04-16 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Fibromyalgia is a complex widespread pain disorder. OBJECTIVES To evaluate the effectiveness of oral magnesium supplementation in reducing symptom severity among fibromyalgia patients who have not responded to standard treatment, using validated scoring systems such as the Fibromyalgia Impact Questionnaire Revised (FIQR).
Eligibility Criteria
Inclusion Criteria: 1. Patients diagnosed with FM according to the American College of Rheumatology (ACR) 2016 criteria 2. Age: 18-65 years. 3. Not responding to conventional treatment (e.g., amitriptyline, duloxetine, pregabalin) for at least 8 weeks 4. Patients giving informed consent for enrollment in the study. Exclusion Criteria: * 1- Patients with renal impairment 2- Pregnant or lactating women 3- Already on magnesium or other mineral supplements 4- Known cases of inflammatory arthritis or other chronic pain syndromes
Contact & Investigator
Masooma Hashmat, FCPS
PRINCIPAL INVESTIGATOR
Shaikh Zayed Hospital, Lahore
Frequently Asked Questions
Who can join the NCT07585045 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Fibromyalgia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07585045 currently recruiting?
Yes, NCT07585045 is actively recruiting participants. Contact the research team at masoomahashmat@gmail.com for enrollment information.
Where is the NCT07585045 trial being conducted?
This trial is being conducted at Lahore, Pakistan.
Who is sponsoring the NCT07585045 clinical trial?
NCT07585045 is sponsored by Shaikh Zayed Hospital, Lahore. The principal investigator is Masooma Hashmat, FCPS at Shaikh Zayed Hospital, Lahore. The trial plans to enroll 86 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.